Posted by Questionmark on October 31, 2008, at 18:44:06
I have been asked if I would be interested in participating (if I was accepted, of course) in a late phase placebo-controlled study on the RIMA (reversible inhibitor of MAO-A) Tyrima. There is no monetary compensation and I would have to forgo Nardil for awhile. Since, based on what i've read, it doesn't seem to be any more special than moclobemide (except for a somewhat longer half-life), I'm probably not even going to bother. But I am somewhat curious (besides it being for a good cause of sorts, more or less).
Fellow Babblers, your opinions: yay or nay?
poster:Questionmark
thread:860116
URL: http://www.dr-bob.org/babble/20081027/msgs/860116.html